Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
International Journal of Molecular Sciences · 16.04.2025 · 26 (8) · 3774
DOI: 10.3390/ijms26083774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.04.2025. Verfasst von Xiangge Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Neurodegenerative Diseases, Models, Biological. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hundred Talents Program of Hebei Province, Hebei Provincial Natural Science Foundation Precision Medicine Joint Fund Cultivation Project.
Abstract (Originalsprache)
Over the past two decades, significant advancements have been made in the induced pluripotent stem cell (iPSC) technology. These developments have enabled the broader application of iPSCs in neuroscience, improved our understanding of disease pathogenesis, and advanced the investigation of therapeutic targets and methods. Specifically, optimizations in reprogramming protocols, coupled with improved neuronal differentiation and maturation techniques, have greatly facilitated the generation of iPSC-derived neural cells. The integration of the cerebral organoid technology and CRISPR/Cas9 genome editing has further propelled the application of iPSCs in neurodegenerative diseases to a new stage. Patient-derived or CRISPR-edited cerebral neurons and organoids now serve as ideal disease models, contributing to our understanding of disease pathophysiology and identifying novel therapeutic targets and candidates. In this review, we examine the development of iPSC-based models in neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, China.
- Human Brain Bank, Hebei Medical University, Shijiazhuang 050017, China.
- The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang 050017, China.
- Hebei Key Laboratory of Neurodegenerative Disease Mechanism, Hebei Medical University, Shijiazhuang 050017, China.
Förderung
- National Natural Science Foundation of China
- Hundred Talents Program of Hebei Province
- Hebei Provincial Natural Science Foundation Precision Medicine Joint Fund Cultivation Project
- Key laboratory of Neural and Vascular Biology, Ministry of Education of China
- Natural Science Foundation of China
- Hebei Provincial Natural Science Foundation’s Precision Medicine Joint Fund’s Cultivation Project
- Key Laboratory of Neural and Vascular Biology of the Ministry of Education of China
Zitieren
APA
Guo, X., Wang, X., Wang, J., Ma, M., & Ren, Q. (2025). Current Development of iPSC-Based Modeling in Neurodegenerative Diseases. International Journal of Molecular Sciences, 26(8), 3774. https://doi.org/10.3390/ijms26083774
Vancouver
Guo X, Wang X, Wang J, Ma M, Ren Q. Current Development of iPSC-Based Modeling in Neurodegenerative Diseases. International Journal of Molecular Sciences. 2025;26(8):3774. doi:10.3390/ijms26083774
BibTeX
@article{Guo2025,
author = {Guo, Xiangge and Wang, Xumeng and Wang, Jiaxuan and Ma, Min and Ren, Qian},
title = {Current Development of iPSC-Based Modeling in Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3774},
doi = {10.3390/ijms26083774}
}
EUVIMED